The North America Atrial Fibrillation market is expected to reach US$ 6,284.87 Mn by 2027 from US$ 2,285.69 Mn in 2019. The market is estimated to grow at a CAGR of 13.7% from 2020 to 2027.
The rise of the Atrial Fibrillation market is driven by factors such as the rising number of patients suffering with cardiovascular diseases and rising awareness towards cardiovascular disease. Restraining factor such as high cost of atrial fibrillation devices and procedures is likely to have negative impact on the growth of the market in the coming years.
Atrial fibrillation is among the most commonly occurring heart condition, which causes irregular and often abnormally fast heart rates, which can lead to the possibility of a stroke. A large number of populations across the globe are unaware of the symptoms associated with atrial fibrillation and hence remain untreated. For instance, Health Innovation Manchester in November 2018 raised awareness regarding Atrial Fibrillation and other innovative technologies to increase the detection of the disease as part of the Global AF Aware Week.
Other than bodies such as associations and organizations, companies in the market have also played an instrumental role in increasing the awareness regarding atrial fibrillation. For instance, Biosense Webster, a Division of Johnson & Johnson, launched two major initiatives as a part of the Global AF Aware Week, which falls between 18–24 November. As a part of the action named Get Smart About AFIB (GSAAF), the company entered into a strategic partnership with the Arrhythmia Alliance to increase knowledge of AF across the healthcare community and the general public. As awareness helps in improving the medical care needed for the treatment of atrial fibrillation, the market is expected to witness considerable growth during the forecast period
US is expected to dominate the market in the North America region, owing to the growing geriatric population and rising number of innovations in healthcare. Hence, considering the mentioned factors, the atrial fibrillation market is expected to grow at a significant pace in the US during the forecast period.
US Atrial Fibrillation Market Revenue and Forecasts to 2027 (US$ Mn)
North America Atrial Fibrillation - MARKET SEGMENTATION
North America Atrial Fibrillation Market - By Treatment
North America Atrial Fibrillation Market - By End User
North America Atrial Fibrillation Market - By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 2,285.69 Million |
| Market Size by 2027 | US$ 6,284.87 Million |
| CAGR (2020 - 2027) | 13.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Treatment Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Atrial Fibrillation Market is valued at US$ 2,285.69 Million in 2019, it is projected to reach US$ 6,284.87 Million by 2027.
As per our report North America Atrial Fibrillation Market, the market size is valued at US$ 2,285.69 Million in 2019, projecting it to reach US$ 6,284.87 Million by 2027. This translates to a CAGR of approximately 13.7% during the forecast period.
The North America Atrial Fibrillation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Atrial Fibrillation Market report:
The North America Atrial Fibrillation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Atrial Fibrillation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Atrial Fibrillation Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Atrial Fibrillation Market
